Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance (Nature Communications, 2021)

(untitled) - Zatreanu, D; Robinson, H; Alkhatib, O; Prevo, R; Higgins, G; Smith, G; Lord, C; Et al